BRESCIA, Italy, May 26, 2025 /PRNewswire/ -- At a time when secure and traceable access to medicine is increasingly essential…
– Largest hypertension trial of an aldosterone synthase inhibitor to date demonstrated the efficacy of lorundrostat in over 1,000 participants…
Positive recommendation based on phase III INAVO120 data showing ItovebiTM (inavolisib) in combination with palbociclib and fulvestrant more than doubled…
Study Demonstrated 87% Overall Response Rate in Metastatic Prostate Cancer Patients Treated with SYNC-T, a First-in-Class In Situ Personalized Immunotherapy…
RAMSEY, N.J., May 22, 2025 /PRNewswire/ -- Tap Native, a leading healthcare-focused digital advertising platform, today announced the launch of…
BURLINGTON, Mass., May 22, 2025 /PRNewswire/ -- Clymb Clinical is proud to announce the launch of TFL Viewer, a state-of-the-art…
IRVINE, Calif., May 22, 2025 /PRNewswire/ -- GATC Health Corp, a leading tech-bio company leveraging artificial intelligence (AI) to transform…
Agreement aims to enhance patient outcomes through the early detection of hard-to-detect diseases like chronic kidney disease. CRYSTAL LAKE, Ill.--(BUSINESS…
WALTHAM, Mass., May 22, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission…
CHATHAM, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a fully-integrated biotechnology company with marketed…